nVerses Capital LLC Takes Position in The Allstate Co. (NYSE:ALL)

nVerses Capital LLC acquired a new stake in shares of The Allstate Co. (NYSE:ALL - Free Report) in the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor acquired 5,200 shares of the insurance provider's stock, valued at approximately $986,000.

Several other hedge funds and other institutional investors also recently made changes to their positions in ALL. BDF Gestion acquired a new position in Allstate in the 2nd quarter worth approximately $3,051,000. BNP Paribas Financial Markets boosted its position in shares of Allstate by 55.8% in the first quarter. BNP Paribas Financial Markets now owns 218,629 shares of the insurance provider's stock worth $37,825,000 after buying an additional 78,316 shares during the period. OFI Invest Asset Management acquired a new position in Allstate during the second quarter valued at $476,000. Envestnet Portfolio Solutions Inc. lifted its stake in Allstate by 12.5% in the 1st quarter. Envestnet Portfolio Solutions Inc. now owns 50,383 shares of the insurance provider's stock worth $8,717,000 after acquiring an additional 5,586 shares in the last quarter. Finally, SG Americas Securities LLC boosted its position in Allstate by 251.8% during the 1st quarter. SG Americas Securities LLC now owns 53,090 shares of the insurance provider's stock worth $9,185,000 after acquiring an additional 38,001 shares during the period. 76.47% of the stock is currently owned by institutional investors and hedge funds.

Allstate Stock Performance

NYSE:ALL traded down $0.14 during mid-day trading on Thursday, hitting $195.51. 1,905,711 shares of the company's stock traded hands, compared to its average volume of 1,550,828. The Allstate Co. has a 12 month low of $121.70 and a 12 month high of $198.79. The firm has a market capitalization of $51.60 billion, a price-to-earnings ratio of 43.18, a price-to-earnings-growth ratio of 1.74 and a beta of 0.48. The firm has a 50 day moving average of $185.67 and a two-hundred day moving average of $173.49. The company has a current ratio of 0.36, a quick ratio of 0.36 and a debt-to-equity ratio of 0.49.

Allstate (NYSE:ALL - Get Free Report) last posted its quarterly earnings results on Wednesday, July 31st. The insurance provider reported $1.61 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.33 by $1.28. Allstate had a net margin of 5.03% and a return on equity of 24.05%. The company had revenue of $15.71 billion for the quarter, compared to analyst estimates of $14.04 billion. During the same period last year, the business posted ($4.42) EPS. The business's quarterly revenue was up 12.4% on a year-over-year basis. On average, equities analysts forecast that The Allstate Co. will post 15.19 earnings per share for the current fiscal year.

Insider Transactions at Allstate

In other Allstate news, EVP Robert Toohey sold 16,682 shares of the business's stock in a transaction on Monday, August 19th. The shares were sold at an average price of $180.17, for a total value of $3,005,595.94. Following the sale, the executive vice president now owns 4,873 shares of the company's stock, valued at $877,968.41. The trade was a 0.00 % decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through this link. In other Allstate news, EVP Robert Toohey sold 16,682 shares of the firm's stock in a transaction dated Monday, August 19th. The shares were sold at an average price of $180.17, for a total transaction of $3,005,595.94. Following the completion of the transaction, the executive vice president now owns 4,873 shares in the company, valued at $877,968.41. This trade represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, insider John E. Dugenske sold 36,367 shares of the company's stock in a transaction that occurred on Friday, September 20th. The shares were sold at an average price of $191.38, for a total value of $6,959,916.46. Following the completion of the sale, the insider now owns 27,364 shares in the company, valued at approximately $5,236,922.32. This represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last quarter, insiders have sold 192,530 shares of company stock valued at $34,967,665. 1.80% of the stock is owned by corporate insiders.

Wall Street Analyst Weigh In

Several analysts recently commented on the stock. Keefe, Bruyette & Woods raised their price target on shares of Allstate from $199.00 to $208.00 and gave the stock an "outperform" rating in a report on Monday, August 12th. JPMorgan Chase & Co. boosted their price target on shares of Allstate from $205.00 to $207.00 and gave the company an "overweight" rating in a report on Thursday, October 10th. UBS Group lifted their price objective on Allstate from $215.00 to $216.00 and gave the company a "buy" rating in a research report on Tuesday. Roth Mkm reaffirmed a "buy" rating and issued a $200.00 target price on shares of Allstate in a research report on Wednesday, August 14th. Finally, StockNews.com lowered Allstate from a "strong-buy" rating to a "buy" rating in a report on Wednesday, August 21st. One research analyst has rated the stock with a sell rating, two have given a hold rating, fourteen have assigned a buy rating and one has given a strong buy rating to the company's stock. Based on data from MarketBeat, Allstate has a consensus rating of "Moderate Buy" and an average price target of $201.06.

Allstate Profile

The Allstate Corporation, together with its subsidiaries, provides property and casualty, and other insurance products in the United States and Canada. It operates in five segments: Allstate Protection; Protection Services; Allstate Health and Benefits; Run-off Property-Liability; and Corporate and Other segments.